NO913659L - Hemming av hiv ved anvendelse av synergistiske kombinasjoner av nukleosidderivater. - Google Patents

Hemming av hiv ved anvendelse av synergistiske kombinasjoner av nukleosidderivater.

Info

Publication number
NO913659L
NO913659L NO91913659A NO913659A NO913659L NO 913659 L NO913659 L NO 913659L NO 91913659 A NO91913659 A NO 91913659A NO 913659 A NO913659 A NO 913659A NO 913659 L NO913659 L NO 913659L
Authority
NO
Norway
Prior art keywords
hiv
inhibition
nucleoside derivatives
synergistic combinations
synergistic
Prior art date
Application number
NO91913659A
Other languages
English (en)
Norwegian (no)
Other versions
NO913659D0 (no
Inventor
Vera Brankovan
Richard J White
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of NO913659D0 publication Critical patent/NO913659D0/no
Publication of NO913659L publication Critical patent/NO913659L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO91913659A 1989-03-17 1991-09-17 Hemming av hiv ved anvendelse av synergistiske kombinasjoner av nukleosidderivater. NO913659L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32493489A 1989-03-17 1989-03-17
US40190889A 1989-09-01 1989-09-01
PCT/US1990/001424 WO1990011081A1 (en) 1989-03-17 1990-03-16 Inhibition of hiv using synergistic combinations of nucleoside derivatives

Publications (2)

Publication Number Publication Date
NO913659D0 NO913659D0 (no) 1991-09-17
NO913659L true NO913659L (no) 1991-10-18

Family

ID=26984692

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91913659A NO913659L (no) 1989-03-17 1991-09-17 Hemming av hiv ved anvendelse av synergistiske kombinasjoner av nukleosidderivater.

Country Status (19)

Country Link
EP (1) EP0464137A4 (xx)
JP (1) JPH04504850A (xx)
KR (1) KR920700653A (xx)
CN (1) CN1045791A (xx)
AU (1) AU5351490A (xx)
CA (1) CA2050473A1 (xx)
DD (1) DD301787A9 (xx)
FI (1) FI914367A0 (xx)
GR (1) GR1000618B (xx)
HU (1) HU208254B (xx)
IL (1) IL93783A0 (xx)
NO (1) NO913659L (xx)
NZ (1) NZ232912A (xx)
OA (1) OA09555A (xx)
PL (1) PL284343A1 (xx)
PT (1) PT93449A (xx)
WO (1) WO1990011081A1 (xx)
YU (1) YU53790A (xx)
ZW (1) ZW3290A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0513917T4 (da) * 1991-05-16 2001-06-25 Glaxo Group Ltd Antivirale kombinationer indeholdende nukleosidanaloger
CA2335617C (en) * 1998-06-24 2009-12-15 Emory University Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv
AU2002255707A1 (en) 2001-03-15 2002-10-03 Trustees Of Boston College, The Selective anti-viral nucleoside chain terminators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987001284A1 (en) * 1985-08-26 1987-03-12 United States Of America, Represented By The Unite Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxynosine, 2',3'-dideoxyguanosine, or 2',3'-dideoxyadenosine
GB8712115D0 (en) * 1987-05-22 1987-06-24 Hoffmann La Roche Pyrimidine derivatives
US4837311A (en) * 1987-06-22 1989-06-06 Hoffman-La Roche Inc. Anti-retroviral compounds
NZ226672A (en) * 1987-10-30 1991-07-26 Hoffmann La Roche 6-amino-9-(2,3-dideoxy-2-fluoro-b-d-threopentofuranosyl)-9h-purine derivatives and pharmaceutical compositions
US4908440A (en) * 1987-11-12 1990-03-13 Bristol Myers Company 2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides

Also Published As

Publication number Publication date
OA09555A (en) 1993-01-31
HUT57988A (en) 1992-01-28
PL284343A1 (en) 1991-06-03
GR1000618B (el) 1992-08-31
NO913659D0 (no) 1991-09-17
EP0464137A1 (en) 1992-01-08
ZW3290A1 (en) 1990-11-07
JPH04504850A (ja) 1992-08-27
CN1045791A (zh) 1990-10-03
CA2050473A1 (en) 1990-09-18
GR900100189A (en) 1990-07-31
YU53790A (sh) 1993-05-28
FI914367A0 (fi) 1991-09-17
HU208254B (en) 1993-09-28
PT93449A (pt) 1990-11-07
DD301787A9 (de) 1994-01-13
NZ232912A (en) 1992-06-25
KR920700653A (ko) 1992-08-10
AU5351490A (en) 1990-10-22
EP0464137A4 (en) 1992-01-15
IL93783A0 (en) 1990-12-23
WO1990011081A1 (en) 1990-10-04
HU902898D0 (en) 1991-12-30

Similar Documents

Publication Publication Date Title
NO885106L (no) Fremgangsmaate ved fremstilling av cytidin-derivater.
DE3864582D1 (de) Alkoxy-substituierte dihydrobenzpyran-2-carboxylat-derivate.
NO852994L (no) Fremgangsmaate ved fremstilling av glutaramidderivater.
DE69008682D1 (de) Guanidinobenzolderivate.
NO900742D0 (no) Sammenstilling av verktoeydeler.
NO930047L (no) Hiv-inhiberende benzenacetamidderivater
ATE124407T1 (de) Chromanderivate.
ATE119146T1 (de) Substituierte bicycloheptadionderivate.
ATE116985T1 (de) Chromanderivate.
DE69017657D1 (de) Pyridinderivate.
NO854655L (no) Fremgangsmaate ved fremstilling av flavolignanderivateer.
NO913659D0 (no) Hemming av hiv ved anvendelse av synergistiske kombinasjoner av nukleosidderivater.
ES2021716B3 (es) Procedimiento de ataque de articulos metalicos de circonio.
DE69005904D1 (de) Phenylpyrimidonderivate.
DE59000510D1 (de) N-phenyltetrahydroindazolderivate.
DE59003499D1 (de) 3-Cyano-4-phenyl-pyrrol-Derivate.
DE69002136D1 (de) Saccharidderivate von protocatechualdehyd.
DE69015726D1 (de) Piperidylthiocarbapenem-Derivate.
OA08742A (fr) Dérivés de pyrimidine.
DE69001450D1 (de) Dihydroxynaphthalin-derivate.
DE69004991D1 (de) Diphenyldiacetylenderivate.
ZA901961B (en) Inhibition of hiv using synergistic combinations of nucleoside derivatives
MX19365A (es) Derivados de tetrahidrobencimidazol.
NO912341D0 (no) Fremgangsmaate for fremstilling av inhibitorer av hiv-revers transkiptase.
ES1021294Y (es) Muneco de doble uso.